Loading...

The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments

Chronic plaque psoriasis is an inflammatory skin disease affecting 2–3% of the general population. Approximately one-third of patients are candidates for systemic immunosuppressive treatments, such as synthetic or biological disease-modifying antirheumatic drugs, because of disease extensions, local...

Full description

Saved in:
Bibliographic Details
Published in:Vaccines (Basel)
Main Authors: Gisondi, Paolo, Bellinato, Francesco, Chiricozzi, Andrea, Girolomoni, Giampiero
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7761600/
https://ncbi.nlm.nih.gov/pubmed/33276686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040728
Tags: Add Tag
No Tags, Be the first to tag this record!